![](/img/cover-not-exists.png)
Phase I/II trial of Amplimexon (imexon, inj.) plus dacarbazine in patients with stage III or IV malignant melanoma
Weber, J., Samlowski, W., Stephenson, J., Ribas, A., O??Day, S., Rene, G., Dorr, R., Grenier, K., Hersh, E.Volume:
16
Language:
english
Journal:
Melanoma Research
DOI:
10.1097/00008390-200609001-00157
Date:
September, 2006
File:
PDF, 44 KB
english, 2006